{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:45:49Z","timestamp":1764701149454},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clinbiochem.2024.110801","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T23:49:42Z","timestamp":1721260182000},"page":"110801","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discrepancy between estimated glomerular filtration rate by creatinine versus cystatin C in different patient care settings"],"prefix":"10.1016","volume":"131-132","author":[{"given":"Li","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent B.","family":"Lewandrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand S.","family":"Dighe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.clinbiochem.2024.110801_b0005","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl. J. Med."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110801_b0010","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am. J. Kidney Dis."},{"issue":"19","key":"10.1016\/j.clinbiochem.2024.110801_b0015","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1056\/NEJMoa2103753","article-title":"Race, genetic ancestry, and estimating kidney function in CKD","volume":"385","author":"Hsu","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110801_b0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MNH.0000000000000115","article-title":"Cystatin C as a biomarker for estimating glomerular filtration rate","volume":"24","author":"Ferguson","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110801_b0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.ajkd.2021.10.001","article-title":"Removing Race from kidney disease diagnosis","volume":"79","author":"Quaggin","year":"2022","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110801_b0030","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.ajkd.2020.05.018","article-title":"The difference between cystatin C- and creatinine-based estimated GFR and incident frailty: an analysis of the cardiovascular health study (CHS)","volume":"76","author":"Potok","year":"2020","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110801_b0035","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.ajkd.2020.05.017","article-title":"The difference between cystatin C- and creatinine-based estimated gfr and associations with frailty and adverse outcomes: a cohort analysis of the systolic blood pressure intervention trial (SPRINT)","volume":"76","author":"Potok","year":"2020","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110801_b0040","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0197-2456(91)90069-X","article-title":"Design and statistical issues of the modification of diet in renal disease trial. The modification of diet in renal disease study group","volume":"12","author":"Beck","year":"1991","journal-title":"Control. Clin. Trials"},{"issue":"4 Suppl","key":"10.1016\/j.clinbiochem.2024.110801_b0045","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1016\/S0197-2456(96)00081-5","article-title":"Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study","volume":"17","author":"Wright","year":"1996","journal-title":"Control. Clin. Trials"},{"issue":"22","key":"10.1016\/j.clinbiochem.2024.110801_b0050","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1056\/NEJM199611283352203","article-title":"Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group","volume":"335","author":"Nelson","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110801_b0055","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7326\/0003-4819-141-12-200412210-00009","article-title":"Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease","volume":"141","author":"Rule","year":"2004","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110801_b0060","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110801_b0065","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/MLR.0000000000000735","article-title":"Identifying Increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ elixhauser comorbidity index","volume":"55","author":"Moore","year":"2017","journal-title":"Med. Care"},{"issue":"11","key":"10.1016\/j.clinbiochem.2024.110801_b0070","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"issue":"23","key":"10.1016\/j.clinbiochem.2024.110801_b0075","doi-asserted-by":"crossref","first-page":"648","DOI":"10.21105\/joss.00648","article-title":"comorbidity: An R package for computing comorbidity scores","volume":"3","author":"Gasparini","year":"2018","journal-title":"J. Open Source Software."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110801_b0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12913-020-05999-5","article-title":"Comparing Charlson and Elixhauser comorbidity indices with different weightings to predict in-hospital mortality: an analysis of national inpatient data","volume":"21","author":"Sharma","year":"2021","journal-title":"BMC Health Serv. Res."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110801_b0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/24748706.2017.1404172","article-title":"Elixhauser comorbidity score is the best risk score in predicting survival after mitraclip implantation","volume":"2","author":"Velu","year":"2018","journal-title":"Structural Heart."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110801_b0090","doi-asserted-by":"crossref","first-page":"e2148940","DOI":"10.1001\/jamanetworkopen.2021.48940","article-title":"Association of intraindividual difference in estimated glomerular filtration rate by creatinine vs cystatin C and end-stage kidney disease and mortality","volume":"5","author":"Chen","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110801_b0095","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/jcpt.13235","article-title":"Effects of dose and type of corticosteroids on the divergence between estimated glomerular filtration rates derived from cystatin C and creatinine","volume":"45","author":"Tsushita","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2024.110801_b0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cccn.2005.01.022","article-title":"Early effects of methylprednisolone infusion on serum cystatin C in patients with severe Graves' ophthalmopathy","volume":"356","author":"Manetti","year":"2005","journal-title":"Clin. Chim. Acta"},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2024.110801_b0105","first-page":"203","article-title":"Corticosteroids significantly increase serum cystatin C concentration without affecting renal function in symptomatic heart failure","volume":"62","author":"Zhai","year":"2016","journal-title":"Clin. Lab."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110801_b0110","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ndt\/gfh707","article-title":"Assessment of renal function in recently admitted critically ill patients with normal serum creatinine","volume":"20","author":"Hoste","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110801_b0115","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/ijerph8020514","article-title":"Hospital malnutrition: prevalence, identification and impact on patients and the healthcare system","volume":"8","author":"Barker","year":"2011","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110801_b0120","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2008.638","article-title":"Factors other than glomerular filtration rate affect serum cystatin C levels","volume":"75","author":"Stevens","year":"2009","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110801_b0125","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","article-title":"Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement","volume":"65","author":"Knight","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2024.110801_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/S1665-2681(19)31437-1","article-title":"Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?","author":"Ladero","year":"2012","journal-title":"Ann. Hepatol."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2024.110801_b0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cccn.2003.11.011","article-title":"Increased cystatin C serum concentrations in patients with hepatic diseases of various severities","volume":"341","author":"Chu","year":"2004","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110801_b0140","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00042737-200108000-00013","article-title":"Elevation of serum cystatin C concentrations in patients with chronic liver disease","volume":"13","author":"Takeuchi","year":"2001","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.clinbiochem.2024.110801_b0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.plabm.2017.05.005","article-title":"Evaluation of cystatin C in malignancy and comparability of estimates of GFR in oncology patients","volume":"8","author":"Jones","year":"2017","journal-title":"Pract Lab Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110801_b0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12032-008-9070-2","article-title":"Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C","volume":"26","author":"Tumminello","year":"2009","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110801_b0155","doi-asserted-by":"crossref","first-page":"e0178823","DOI":"10.1371\/journal.pone.0178823","article-title":"Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma","volume":"12","author":"Guo","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110801_b0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biopha.2007.07.001","article-title":"Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications","volume":"62","author":"Tumminello","year":"2008","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110801_b0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/ijmr.IJMR_124_16","article-title":"Utility of cystatin C as a potential bladder tumour biomarker confirmed by surface plasmon resonance technique","volume":"147","author":"Tokarzewicz","year":"2018","journal-title":"Indian J. Med. Res."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110801_b0170","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0961203311425527","article-title":"Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus","volume":"21","author":"Lertnawapan","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.clinbiochem.2024.110801_b0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/ijpvm.IJPVM_619_20","article-title":"Role of cystatin C in predicting disease activity and flare-up in systemic lupus erythematosus: a longitudinal follow-up study","volume":"12","author":"Fatemi","year":"2021","journal-title":"Int. J. Prev. Med."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110801_b0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/03009742.2011.571219","article-title":"Cystatin C concentration is correlated with disease activity in rheumatoid arthritis patients","volume":"40","author":"Targo\u0144ska-Stepniak","year":"2011","journal-title":"Scand. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110801_b0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1373\/clinchem.2004.041889","article-title":"Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate","volume":"51","author":"Koenig","year":"2005","journal-title":"Clin. Chem."},{"issue":"20","key":"10.1016\/j.clinbiochem.2024.110801_b0190","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110801_b0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jcla.21665","article-title":"Clinical utility of serum cystatin C in predicting coronary artery disease in patients without chronic kidney disease","volume":"28","author":"Dandana","year":"2014","journal-title":"J. Clin. Lab. Anal."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110801_b0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCULATIONAHA.106.644286","article-title":"Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study","volume":"115","author":"Ix","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2024.110801_b0205","doi-asserted-by":"crossref","DOI":"10.4158\/EP12282.OR","article-title":"Impact of thyroid function on serum cystatin C and estimated glomerular filtration rate: a cross-sectional study","author":"Ye","year":"2013","journal-title":"Endocr. Pract."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110801_b0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000329354","article-title":"Influence of thyroid function on different kidney function tests","volume":"35","author":"Kimmel","year":"2012","journal-title":"Kidney Blood Press. Res."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110801_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100600","article-title":"Estimated GFR with Cystatin C and creatinine in clinical practice: a retrospective cohort study","volume":"5","author":"Gottlieb","year":"2023","journal-title":"Kidney Med."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110801_b0220","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1373\/clinchem.2016.261925","article-title":"Discrepant results of serum creatinine and cystatin c in a urological patient","volume":"63","author":"van Roij","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2024.110801_b0225","unstructured":"Roche Diagnostics. Indianapolis, IN. CREJ2 Creatinine Jaff\u00e9 Gen.2 Method sheet 2023 [cited 2024 June 18]; V 17.0:[Available from: https:\/\/elabdoc-prod.roche.com\/eLD\/api\/downloads\/4689c608-367e-ee11-2291-005056a71a5d?countryIsoCode=us."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110801_b0230","doi-asserted-by":"crossref","first-page":"628","DOI":"10.5858\/133.4.628","article-title":"Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients","volume":"133","author":"Lippi","year":"2009","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110801_b0235","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/08037051.2012.707336","article-title":"Red cell distribution width and inflammation in patients with non-dipper hypertension","volume":"22","author":"Ozcan","year":"2013","journal-title":"Blood Press."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110801_b0240","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/00365513.2015.1025427","article-title":"Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'","volume":"75","author":"Grubb","year":"2015","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.clinbiochem.2024.110801_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2019.08.001","article-title":"eGFR, cystatin C and creatinine in shrunken pore syndrome","volume":"498","author":"Zhou","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2024.110801_b0250","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2018.01.006","article-title":"Involvement of cystatin C in immunity and apoptosis","volume":"196","author":"Zi","year":"2018","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110801_b0255","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.4049\/jimmunol.1001934","article-title":"IL-10 controls cystatin C synthesis and blood concentration in response to inflammation through regulation of IFN regulatory factor 8 expression","volume":"186","author":"Xu","year":"2011","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110801_b0260","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1253\/circrep.CR-19-0052","article-title":"Serum cystatin C, a sensitive marker of renal function and cardiovascular disease, Decreases after Smoking Cessation","volume":"1","author":"Funamoto","year":"2019","journal-title":"Circ Rep."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110801_b0265","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1507\/endocrj.EJ19-0478","article-title":"Overestimation of glomerular filtration rate calculated from serum creatinine as compared with cystatin C in patients with subclinical hypercortisolism: Hyogo Adrenal Metabolic Registry","volume":"67","author":"Naka","year":"2020","journal-title":"Endocr. J."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202400095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202400095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T21:10:14Z","timestamp":1725916214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991202400095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":53,"alternative-id":["S000991202400095X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110801","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discrepancy between estimated glomerular filtration rate by creatinine versus cystatin C in different patient care settings","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110801"}}